Tag: ASX: TLX
Telix ventures into advanced isotope production with ARTMS acquisition
Telix Pharmaceuticals Limited has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc, its advanced cyclotron-based isotope production platform, manufacturing plant, and stockpile of ultra-pure rare metals required for consumable target production.
ASX-listed Telix Pharmaceuticals unveils potential plan for US listing
Melbourne-based biopharmaceutical giant Telix Pharmaceuticals announced today its plans for an initial public offering in the United States and listing on the Nasdaq Global...
Australian pharma firm Telix opens $21m radiopharmaceutical production facility in Belgium
ASX-listed Telix Pharmaceuticals has recently opened Telix Manufacturing Solutions, the company's radiopharmaceutical production facility in Belgium, serving as the primary manufacturing site for radioisotopes and commercial and clinical products for patients in the Europe Middle East and Africa (EMEA) region.
Featured Article
Australian Manufacturing Week 2026 to make Brisbane debut
Australia’s leading advanced manufacturing showcase, Australian Manufacturing Week (AMW), is set to return in 2026, marking its first-ever event in Brisbane.
